Navigation Links
AMT to Release Full Year 2008 Results on February 24, 2009
Date:2/18/2009

AMSTERDAM, The Netherlands, February 18 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that it will release its financial results for the full year 2008 on Tuesday, February 24, 2009 at 7:00 am Central European Time (CET). To discuss these results, the Company will conduct a conference call that day at 3 p.m. CET.

The dial-in number for the Netherlands is 0800-949-4166 (toll free). The number for Germany is 0800-000-22-63 (toll free). For the UK the number is +44-207-107-0611 and for the rest of Europe: +41-91-610-5600. The number for the USA is +1-866-291-4166 (toll free). To listen to the conference call live via the internet, visit the investor relations portion of the AMT website at http://www.amtbiopharma.com. Please go to the website fifteen minutes prior to the call to register, download and install the necessary audio software.

About Amsterdam Molecular Therapeutics

AMT has a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and scalable AAV GMP production platform. As such, AMT's proprietary platform holds tremendous promise for thousands of (rare) diseases that are caused by one faulty gene. AMT currently has a product pipeline with nine products at different stages of development.

Certain statements in this press release are "forward-looking statements" including those that refer to management's plans and expectations for future operations, prospects and financial condition. Words such as "strategy," "expects," "plans,"
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. New Edition of Definitive Resource in Tissue Engineering Released Today
2. Vital Images Releases Next Generation Enterprise-Wide Solutions Featuring Vitrea(R) 4.0 and ViTALConnect(R) 4.1
3. Instant JChem 2.0 Released: Instant JChem Personal Free for All Users
4. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
5. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
6. Amnis Announces the Release of Multiple Upgrades to the ImageStream(R) System
7. WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007
8. Quigley Corporation Releases Update on Quigley Pharmas Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy
9. Dynatronics to Release Fourth Quarter and Year-end Results Friday, September 14, 2007; Conference Call set for 1:00 p.m. ET
10. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
11. Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the ... randomized, active control Phase 3 study of Zerenex (ferric ... for the treatment of hyperphosphatemia in patients with end-stage ... binding and iRon delivery with FErric CiTrate in EsrD) ... the American Society of Nephrology ( JASN ). ...
(Date:7/24/2014)... , July 24, 2014  Asterias Biotherapeutics, Inc. ... emerging field of regenerative medicine, announced today that ... presentation to investors on Tuesday, July 29, 2014, ... presentation will include an overview of Asterias, business ... webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics at least 15 ...
(Date:7/24/2014)... Yet, scientists are making progress in devising suitable ... approach relies on quantum dotsa kind of artificial ... A new study demonstrates that changing the coupling ... electrical impulses can help better control them. This ... as quantum information units, which would produce faster ...
(Date:7/24/2014)... 2014 Research and Markets has ... Proteomics Analytical Instruments Market 2014-2018" report to their ... Genomics is the study of the gene and ... structure and functions of proteomes or sets of proteins ... Genomics involves the mapping of genes and DNA sequencing ...
Breaking Biology Technology:Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 2
... Acquisition Extends Elsevier,s Ability to Gather Global Healthcare News and, ... Increase ... Business Value for Customers, PHILADELPHIA, March 10 ... information, announced,today that it has acquired Windhover Information Inc., a ...
... March 10 Caliper Life,Sciences, Inc. (Nasdaq: ... the,Cowen and Company 28th Annual Health Care Conference ... at 2:30 p.m. EDT. Kevin Hrusovsky, President,and CEO ... the company,s business.,The live webcast can be accessed ...
... used by Avexa to select patients and optimize ... background therapy in phase III program, SOUTH SAN FRANCISCO, ... today that the Company,has signed an agreement with AVEXA Limited (ASX: ... technology in support of,Avexa,s drug discovery and development programs., Avexa ...
Cached Biology Technology:Elsevier Acquires Windhover Information Inc., a Healthcare Business Intelligence Company 2Elsevier Acquires Windhover Information Inc., a Healthcare Business Intelligence Company 3Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts 2Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts 3Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts 4Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts 5
(Date:7/27/2014)... Dinosaurs might have survived the asteroid strike that wiped ... or later in history, scientists say. , A fresh ... has helped palaeontologists to build a new narrative of ... , They found that in the few million years ... Earth was experiencing environmental upheaval. This included extensive volcanic ...
(Date:7/27/2014)... the potential for global climate change to cut food ... ignored the interactions between increasing temperature and air pollution ... crops. , A new study involving researchers at MIT ... that policymakers need to take both warming and air ... study looked in detail at global production of four ...
(Date:7/25/2014)... In the first broad-scale estimate of air pollution removal ... calculated that trees are saving more than 850 human ... respiratory symptoms. , While trees, pollution removal equated to ... percent, the impacts of that improvement are substantial. Researchers ... pollution at nearly $7 billion every year in a ...
Breaking Biology News(10 mins):Dinosaurs fell victim to perfect storm of events, study shows 2Study: Climate change and air pollution will combine to curb food supplies 2Study: Climate change and air pollution will combine to curb food supplies 3First national study finds trees saving lives, reducing respiratory problems 2
... (VIB) connected to the University of Antwerp are the first ... cells is a major risk factor for Alzheimer's disease. Amyloid ... of the senile plaques in the brains of patients. The ... protein that is produced, the younger the dementia patient is. ...
... glow emitted by a variety of sea coral helped ... to create a tiny fluorescent tag that responds to ... individual proteins as they dart around inside living cells. ... it is derived from the sea coral Dendronephthya--first shows ...
... to skim through text, instantly recognizing words by their ... after humans evolved. Thus, neuroscientists have hotly debated ... Word Form Area (VWFA) is truly a specific and ... have shown that the area specifically activates when people ...
Cached Biology News:The urban evolution lab 2Sea coral's trick helps scientists tag proteins 2Sea coral's trick helps scientists tag proteins 3'Word-vision' brain area confirmed 2